The association of cardiovascular failure with treatment for ventilator-associated lower respiratory tract infection

Autor: Fernando Zampieri, Ali AIT HSSAIN, Prof. Ignacio Martin-loeches, Angel Estella, Francois Philippart, Erika Parmentier-Decrucq, Philippe Seguin, Sebastien Preau, Antonia Socias Mir, Pierre Pasquier, Carmen Lab, Miguel Ferrer, Team3 Carmen
Rok vydání: 2019
Předmět:
Zdroj: Martin-Loeches, I, Torres, A, Povoa, P, Zampieri, F G, Salluh, J, Nseir, S, Ferrer, M, Rodriguez, A & TAVeM study Group 2019, ' The association of cardiovascular failure with treatment for ventilator-associated lower respiratory tract infection ', Intensive Care Medicine, vol. 45, no. 12, pp. 1753-1762 . https://doi.org/10.1007/s00134-019-05797-6
ISSN: 1432-1238
0342-4642
Popis: PURPOSE: Ventilator associated-lower respiratory tract infections (VA-LRTIs), either ventilator-associated pneumonia (VAP) or tracheobronchitis (VAT), accounts for most nosocomial infections in intensive care units (ICU) including. Our aim was to determine if appropriate antibiotic treatment in patients with VA-LRTI will effectively reduce mortality in patients who had cardiovascular failure.METHODS: This was a pre-planned subanalysis of a large prospective cohort of mechanically ventilated patients for at least 48 h in eight countries in two continents. Patients with a modified Sequential Organ Failure Assessment (mSOFA) cardiovascular score of 4 (at the time of VA-LRTI diagnosis and needed be present for at least 12 h) were defined as having cardiovascular failure.RESULTS: VA-LRTI occurred in 689 (23.2%) out of 2960 patients and 174 (25.3%) developed cardiovascular failure. Patients with cardiovascular failure had significantly higher ICU mortality than those without (58% vs. 26.8%; p CONCLUSIONS: Patients with VA-LRTI and cardiovascular failure did not show an association to a higher ICU survival with appropriate antibiotic treatment. Additionally, we found that in patients without cardiovascular failure, appropriate antibiotic treatment conferred a survival benefit for patients only with VAP.TRIAL REGISTRY: ClinicalTrials.gov, number NCT01791530.
Databáze: OpenAIRE